2015
DOI: 10.1182/blood-2015-01-618215
|View full text |Cite
|
Sign up to set email alerts
|

Allogeneic cell transplant expands bone marrow distribution by colonizing previously abandoned areas: an FDG PET/CT analysis

Abstract: Key Points Allogeneic hematopoietic stem cells colonize, other than axial niches, appendicular BM that is abandoned in normal subjects. Bone marrow expansion into distal sites differs between cord blood and adult hematopoietic stem cells.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
17
0

Year Published

2015
2015
2022
2022

Publication Types

Select...
5
3

Relationship

2
6

Authors

Journals

citations
Cited by 23 publications
(17 citation statements)
references
References 28 publications
0
17
0
Order By: Relevance
“…This computational approach is commonly used in commercially available software for 3D representation of the skeleton, and its potential has been previously validated in our laboratory for the characterization of intraosseous volume and bone marrow metabolic activity [15, 25, 26]. However, thresholding the Hounsfield values on the CT images is not effective in this application since the spinal canal is not directly surrounded by osseous tissue in all slices.…”
Section: Discussionmentioning
confidence: 99%
“…This computational approach is commonly used in commercially available software for 3D representation of the skeleton, and its potential has been previously validated in our laboratory for the characterization of intraosseous volume and bone marrow metabolic activity [15, 25, 26]. However, thresholding the Hounsfield values on the CT images is not effective in this application since the spinal canal is not directly surrounded by osseous tissue in all slices.…”
Section: Discussionmentioning
confidence: 99%
“…Using a dedicated software, capable of quantifying volumes of compact (CBV) and trabecular bone (IBV) from X-ray CT slices 22 24 , we already documented a selective erosion of compact bone, which managed to predict patients’ disease-specific survival, providing prognostic information independent from the commonly employed biomarkers 23 . Similarly, Lagenberg et al .…”
Section: Introductionmentioning
confidence: 99%
“…This could give a platform for second generation clinical trials with dose escalation on either RM or YM, dependent on previously achieved clinical data. Recent FDG-PET/CT indicates potential re-distribution of bone marrow after bone marrow transplant (29). The DECT with lower cost and reduced dose exposure, may be easily incorporated in patient management to measure Post-TMI/bone marrow transplant redistribution of marrow compositions and bone damage, similar to our recent report (16).…”
Section: Discussionmentioning
confidence: 99%